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Background: The methicillin resistance of bacteria from the genus Staphylococcus and its ability to form biofilms
are important factors in pathogenesis of these microorganisms. Thus, the search for new antimicrobials agents,
especially from plants, has been intensified. In this context, Terminalia species have been the subject of research for
many pharmacological activities. In this study we evaluated the antibacterial, antibiofilm and cytotoxic activities of
the ethanol extract (EtE) from Terminalia fagifolia stem bark as well as that of three fractions of the extract (AqF,
HaF and WSF).
Methods: We determined the minimum inhibitory concentration (MIC) by microdilution in 96-well plates, where
the strains were exposed to serial dilutions of the ethanol extract and fractions, ranging from 12.5 to 400 μg/mL. We
then determined the minimum bactericidal concentration (MBC), seeding the inoculum (10 μL) with concentrations
equal to or greater than the MIC in Mueller-Hinton agar. To test the antibiofilm activity biofilm formation was induced
in the presence of concentrations equivalent to 1/2, 1/4 and 1/8 of the MIC extract or fraction tested. In addition, the
effect of the EtE and the fractions on cell viability was tested by the MTT assay on human MCF-7 breast cancer and
mouse fibroblast NIH/3T3. To obtain high-resolution images of the effect of the aqueous fraction on the bacterial
morphology, atomic force microscopy (AFM) imaging of treated S. aureus cells was performed.
Results: We observed antibacterial activity of EtE and fractions with MICs ranging from 25–200 μg/mL and MBCs
ranging from 200–400 μg/mL. Regarding antibiofilm activity, both the EtE as the AqF, HaF and WSF fractions showed
significant inhibition of the biofilm formation, with inhibition of biofilms formation of over 80% for some strains. The
EtE and fractions showed a moderate cytotoxicity in cell line NIH/3T3 viability and potential antitumoral activity on
human breast cancer cell line MCF-7. The microscopic images obtained revealed morphological changes to the S.
aureus ATCC 29213 surface caused by AqF, as well as significant size alterations.
Conclusions: The results show potential antibacterial, antibiofilm and antitumoral activities of the ethanol extract and
fractions of T. fagifolia.
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The shortage of new antimicrobial has been character-
ized as a public health emergency and pathogenic micro-
organisms resistant to antimicrobial used in therapy of
infections have appeared both in the community and in
hospitals. Among them, staphylococci stand out because
they belong to a diverse group of bacteria that cause
diseases ranging from skin infections to bacteremia.
The two major opportunistic pathogens of this genus,
Staphylococcus aureus and Staphylococcus epidermidis,
colonize a considerable portion of the human popula-
tion [1-3].
Staphylococcus aureus can cause a range of serious in-
fections, with rates of morbidity and mortality of up to
64%, this pathogenicity reflects its ability to produce a
variety of toxins, and to firmly adhere to prosthetic ma-
terials, apart from the capacity to develop resistance to
antimicrobial agents [4]. S. epidermidis, despite being an
important commensal, has emerged as the most signifi-
cant pathogen related to the implantation of medical
devices infections [5-7].
Resistance to methicillin is an additional important
factor in the establishment of infections caused by S.
aureus or by S. epidermidis and it is becoming more and
more prevalent. This resistance profile, along with the
ability to form biofilm complicates the treatment of
infections caused by these pathogens [8-11].
After the establishment of the biofilm, the diffusion of
antibiotics is hampered, the inner layers bacteria begin
to have a low metabolic rate, physiological changes
occur in the growth mode, among other mechanisms of
resistance [12]. New strategies are needed to remove
these infections mediated by the biofilm. In this context
a renewed interest in natural substances has drawn at-
tention to plants rich in secondary metabolites, known
for their antimicrobial properties [13].
The Terminalia genus, belonging to the Combreta-
ceae family, comprising around 200 species widely
used in folk medicine, Terminalia fagifolia Mart. is
found in the Brazilian Cerrado and known popularly as
“capitão, capitão-do-cerrado, capitão-do-campo and
mirindiba” [14].
From the stem bark of T. fagifolia two 1,3-diarylpro-
panes, seven flavanones, two chalcones, one flavan, nine
triterpenes, gallic acid and sitosterol have been charac-
terized by Nuclear Magnetic Resonance (NMR) [15].
Previous studies on ethanol extracts of the T. fagifolia
Mart. leaves have also revealed the presence of several
specific chemical compounds, such as (+)-catechin,
sitosterol-3-O-β-D-glucopyranoside, α- and β-tocopherol,
a mixture of lupeol, α- and β-amyrin, and a mixture of
glycosides flavonoids [16]. These compounds exhibit
potential antibacterial activity among several other
pharmacological activities [15,16].Therefore, this study aimed to test the antibiofilm ac-
tivity the ethanol extract and aqueous, hydroalcoholic
and water-soluble fractions of the stem bark of the
Terminalia fagifolia Mart. (Combretaceae) against sensi-
tive and resistant bacteria of the genus Staphylococcus sp.
Materials and methods
Plant material
The stem bark of T. fagifolia were collected in November
2006 in the city of Timon, Maranhão State, Brazil. The
species was identified by Dr. Gardene Maria de Souza of
the Graziela Barroso Herbarium, Federal University of
Piauí, where a specimen was deposited under TEPB
number 21691.
Extraction
The stem bark of the T. fagifolia was air dried, crushed
and subjected to a maceration process six times with
ethanol (1:1) at room temperature. After removal of the
solvent on a rotary evaporator (55°C under reduced
pressure) followed by lyophilization, ethanol extract
(EtE) was obtained. A portion of the extract was sepa-
rated for biological testing and the remaining material
was suspended in 1,200 mL of a mixture of H2O/MeOH
(2:1) and partitioned with ethyl acetate. The organic
phase was concentrated, then suspended in MeOH/H2O
(9:1), and finally extracted with hexane, thus providing
the following fractions: aqueous (AqF), hydroalcoholic
(HaF) and hexane (not used in this study), in addition to
the water-soluble precipitate (WSF) [17].
Bacterial strains and inoculum standardization
Ethanol extract (EtE) and its aqueous (AqF), hydroalco-
holic (HaF) and water-soluble (WSF) fractions were tested
against Staphylococcus aureus (ATCC 29213), S. aureus
COL (MRSA, Methicillin Resistant Staphylococcus aur-
eus), S. aureus WB69 (MRSA), Staphylococcus epidermidis
(ATCC 12228), S. epidermidis H111 (MRSE - Methicillin
Resistant Staphylococcus epidermidis) and S. epidermidis
70D (MRSE). Bacteria were spread over Mueller-Hinton
agar and aerobically incubated for 24 h at 37°C, after
which they were collected and suspended in sterile saline
[0.85% NaCl (w/v)] to reach an absorbance between 0.08
and 0.10, at 625 nm was obtained, representing approxi-
mately 1–2 × 108 CFU/mL. This bacterium solution was
diluted 1:10 and used for the following procedures.
Antibacterial activity
Minimum inhibitory concentration (MIC) determina-
tions were performed through microdilution of the
Mueller–Hinton broth following the recommenda-
tions of the CLSI [18]. Thus 8 μL of each extract or
fraction were added to microtiter wells containing
187 μL Mueller-Hinton broth followed by 2-fold
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12.5 - 400 μg/mL.
The standardized inoculum (5 μL) was added to give a
final concentration of 5 × 105 CFU/mL, reaching a final
volume of 100 μL in each well. In addition, Oxacilin (for
sensitive strains) and Vancomicin (for MRSA and
MRSE) were included in other microplate. Bacterial
growth control consisted of 95 μL of culture medium
and 5 μL of bacteria inoculums added to three wells.
DMSO was used as a negative control. After incubation
at 37°C for 24 h, MIC was defined as the lowest concen-
tration of extract at which no visible growth could be
detected. The results were enhanced by the use of 10 μL
of Triphenyl Tetrazolium Chloride 1% (TTC) (Sigma, St.
Louis, MO, USA), which may be reduced when there is
bacterial growth, forming the triphenyl formazan with
red color.
In order to determine the minimal bactericidal con-
centration (MBC), 10 μl of the wells that showed results
equal to or greater than the MIC were seeded onto
Mueller-Hinton Agar (MHA), before TTC addition.
After 24 h of incubation at 37°C, the MBC was considered
the lowest concentration that inhibited visible bacterial
growth on the agar. All the tests were performed in
triplicate.
Antibiofilm activity
The assay was performed in 96 well microtiter plates, to
each well we added the bacterial suspension (5×105
CFU/mL), the ethanol extract and its fractions at con-
centrations less than MIC (1/2, 1/4 and 1/8 of the MIC)
and TSB medium (Tryptical Soya Broth) which was sup-
plemented with 0.5% glucose, then the microplate was
incubated at 37°C for 24 h under aerobic conditions.
After this incubation period, the culture medium was re-
moved and the wells washed twice with distilled water.
Then, the biofilm was fixed with 100 μL of Methanol
(PA) for 15 minutes, stained with crystal violet 0.1% (v/v)
and rinsed with water. Biofilm formation was evaluated by
adding 100 μL of 95% ethanol to the wells, and the plates
subjected to spectrophotometric reading at 630 nm, ac-
cording to Stepanovic et al. [19] with modifications. The
results were expressed as percent inhibition of biofilm for-
mation, considering the absorbance of the positive control
(wells to which no potential antibacterial agents were
added) as 0% inhibition. All tests were made in quadrupli-
cate (four replicate wells).
Cell culture
The human breast cancer cell line MCF-7 was pur-
chased from American Type Culture Collection (ATCC)
and murine fibroblast cell line NIH/3T3 was purchased
from the Cell Bank of the Federal University of Rio de
Janeiro (Rio de Janeiro, Brazil). The cells were routinelymaintained in culture flasks (TPP, Switzerland), at 37°C
in 5% CO2, in DMEM media with 100 IU/mL penicillin
and 100 μg/mL streptomycin supplemented with 10%
(v/v) heat inactivated fetal bovine serum (Life Technolo-
gies, USA).
MTT assay and cytotoxicity analysis
For determining the cytotoxic activity, cells were seeded
on 96-well plates at a density of 5x103 cells per well in
culture medium overnight at 37°C in in 5% CO2. The
medium was changed and cells were incubated with dif-
ferent concentrations of EtE, AqF, HaF, WSF of the T.
fagifolia trunk bark (12.5 – 400 μg/mL) prepared from a
stock solution diluted in Dimethyl Sulfoxide (DMSO).
As control groups, cells were treated with DMSO at the
same concentration used in the treatments and cells
treated with normal media (100% cell viability). The final
concentration of DMSO in each well was 1% (v/v) and
the treatments were conducted in triplicate for each ex-
perimental group.
Cell viability was determined by a 3,4,5-dimethyl-
thiazol-2,5 biphenyl tetrazolium bromide (MTT – Life
Technologies, USA) assay. After 24 h treatment, 15 μL
of MTT solution (5 mg/mL in PBS) were added to each
well. After 2 h of incubation at 37°C in 5% CO2, the cul-
ture media was aspirated and 100 μL of DMSO were
added. The absorbance was monitored using a spectro-
photometer with a microplate reader at a wavelength of
595 nm (SpectraMax; Molecular Devices, Sunnyvale,
California, USA).
Atomic Force Microscopy (AFM)
To perform Atomic Force Microscopy (AFM), the MIC
value of aqueous fraction (AqF) against S. aureus ATCC
29213 was determined again as described before, using
inocula of 1–2 × 108 CFU/mL with AqF concentration
ranging from 50 – 800 μg/mL. After incubation for 24
hours, 30 μL of the culture medium containing the
treated (at MIC value) or non-treated bacteria were de-
posited onto a clean glass surface followed by drying in
bacteriological incubator at 35°C for 10 min. The sam-
ples were then gently rinsed with deionized water to re-
move salt crystals, and other unwanted growth medium
components, and dried again under the same conditions,
before AFM analysis. All samples were prepared at the
same time, exposed to the same conditions and exam-
ined within 8 hours of deposition [20]. AFM was carried
out with a TT-AFM microscope from AFM Workshop
(USA). The analysis of the effect of AqF on S. aureus
cells was carried out in vibrating mode, using cantilevers
(NSG10/NT-MDT) with resonant frequency approxi-
mately 240 kHz. Images were analyzed using Gwyddion
software version 2.40. Multiple areas of each sample
were examined and selected representative images from
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are shown.
Statistical analysis
Statistical analysis of the results obtained was done with
the GraphPad Prism ® 5.0 software (GraphPad Sofware
Inc.) for the antibiofilm assay and cell viability assays for
which the analysis of variance (ANOVA) followed by
post-test Tukey or post-test Bonferroni to assess differ-
ences between the groups was carried out. The results
were expressed as the mean ± SEM (Standard Error of
Mean). To compare the size of the bacteria obtained by
AFM, T-test was applied and the results were expressed
as the mean ± SD. A p < 0.05 was considered statistically
significant.
Results and discussion
The results of the minimum inhibitory concentration
(MIC) test showed that the ethanol extract (EtE) and
aqueous (AqF), hydroalcoholic (HaF) and water soluble
(WSF) fractions effectively inhibited the growth of all
strains of S. aureus and S. epidermidis evaluated. The
MICs ranged from 25–200 μg/ml, thereby demonstrat-
ing the potential of these substances as antibacterial
agents, in Table 1 we can see that in general, S. epidermis
was inhibited at lower concentrations by the EtE and frac-
tions than S. aureus. In summary, the AqF was the most
effective, inhibiting all strains tested at 25 to 50 μg/mL,
the EtE was intermediate, being quite effective against the
S. epidermis strains, but less so against S. aureus strains,
and the HaF was the least effective.
After determining the MIC, the minimum bactericidal
concentration (MBC) was determined and it was only
found in some bacteria at the evaluated concentrations.
The AqF had an MBC equal to 400 μg/mL against S. aur-
eus WB69 and S. epidermidis H111 (Methicillin-Resistant
clinical specimens). The lowest MBC found (200 μg/mL)
was for HaF against S. aureus WB69 and S. aureus ATCC
29213. For the S. aureus COL and S. epidermidis 70D
strains, the extract or fractions showed no MBC at the
concentrations tested (Table 1).Table 1 Minimum Inhibitory Concentration and Minimum Bac
and WSF in g/mL
Bacterial strains Ethanol extract Hydroalcoholic fr
MIC MBC MIC M
S. aureus ATCC 29213 100 400 200 2
S. aureus COL 100 >400 200 >
S. aureus WB69 50 >400 100 2
S. epidermidis ATCC 12228 25 400 50 >
S. epidermidis 70D 25 >400 25 >
S. epidermidis H111 25 >400 25 >The indiscriminate use of antibiotics by the population
is one of the causes for the increasing resistance of mi-
croorganisms that result in a reduction of available
therapeutic alternatives. This factor coupled with the
high cost of production of synthetic compounds
prompts further research for new antimicrobials that are
effective against pathogens resistant to currently used
drugs [21].
Herbal medicines may be an alternative because they
present secondary metabolites that are active against a
wide range of microorganisms. Extracts derived from
other plants of the genus Terminalia that have been
studied elsewhere also showed antibacterial effect, but
with lower activity than the results presented above
[21,22]. For instance Bag et al. [23] studying the effect of
the ethanol extract of Terminalia chebula found MIC of
975 μg/mL against S. aureus.
The MIC of an agent for a given microorganism is the
lowest concentration of the agent required to inhibit
growth of a bacterial inoculum in a standardized test,
while the MBC is the lowest concentration that an agent
is able to kill bacteria present in an inoculum. An agent
is generally considered bactericidal if the MBC is less
than or equal to four times the MIC value [24]. Thus,
the T. fagifolia EtE and fractions thereof may be consid-
ered bactericidal to S. aureus ATCC 29213, as well as
the HaF for S. aureus WB69.
The antibacterial effect shown by the EtE and its frac-
tions may be due to the chemical composition of the ex-
tract, which is rich in flavonoids (flavanones, chalcones
and flavanes), 1,3-diarilpropanos, pentacyclic triterpenes
glycosylated and non-glycosylated [15]. In addition, Nunes
et al. [17] suggested the presence of polar compounds
with antimicrobial potential, like flavonoids, glycosylated
flavonoids, and saponins in the AqF and HaF fractions.
Studies describe the action of naturally occurring mol-
ecules as antimicrobial agents such as terpenoids, gluco-
corticoids, flavonoids and polyphenols that are small
molecules produced by plants and are able to inhibit
many bacterial species, particularly Gram-positive mi-
croorganisms. In some cases these microorganisms aretericidal Concentration (MIC and MBC) of EtE, HaF, AqF
action Aqueous fraction Water soluble fraction
BC MIC MBC MIC MBC
00 50 200 50 200
400 50 >400 100 >400
00 50 400 50 400
400 25 400 25 >400
400 25 >400 25 >400
400 25 400 25 >400
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biofilms [25].
With the exception of S. epidermidis ATCC 12228, all
the bacterial strains tested in the previous section are
capable of forming biofilms. Thus, we further examined
the antibiofilm activity of EtE and its partitions (AqF,
HaF and WSF). Both the EtE and the AqF, HaF and
WSF fractions showed inhibition of biofilms, especially
at the highest concentration used. It is noteworthy to
observe that the tested concentrations were equivalent
to 1/8, 1/4 and 1/2 the MIC of each substance in rela-
tion to the different strains tested, and that they ranged
from 100–3.12 μg/ml.
In regards to S. epidermidis 70D (MRSE), only the
WSF showed antibiofilm effect at the three tested con-
centrations (12.5, 6.25 and 3.12 μg/ml). The EtE and
AqF showed antibiofilm activity at the two highest con-
centrations used (6.25 and 12.5 μg/ml) for that strain,
unlike the HaF which exhibited such activity only at the
highest concentration (12.5 μg/ml), as illustrated in
Figure 1. For S. epidermidis H111 (MRSE), only the
highest concentration tested (12.5 μg/ml) and the EtE
fractions (AqF, HaF and WSF) showed statistically sig-
nificant inhibition of biofilm formation (Figure 2).
The biofilm of S. aureus ATCC 29213 was inhibited by
EtE, HaF and AqF at all concentrations used. The WSF
showed inhibition only at the highest concentration.Figure 1 Percent inhibition of biofilm formation exhibited by ethanol extra
S. epidermidis 70D biofilm.Furthermore AqF showed a concentration dependent in-
hibition at the lower concentrations tested for this strain,
25, 12.5 and 6.25 μg/ml (Figure 3). In regards to the S.
aureus COL (MRSA) strain, only AqF showed inhibitory
effect at the lower concentration (6.25 μg/mL), as it can
be seen in Figure 4. Only the EtE was able to inhibit S.
aureus WB69 biofilm at the three concentrations tested
(Figure 5).
The formation of biofilms, highly organized bacterial
complexes, is increasingly recognized as an important
virulence factor for Staphylococcus sp [12]. The antimicro-
bial agents derived from natural products may represent a
suitable alternative to limit this process.
Studies of antibiofilm activity derived from plants of
the Combretaceae family are scarce. The antibiofilm
effect of extracts from various plants of the Brazilian
caatinga has been evaluated, among them one belonging
to Combretaceae, Buchenavia tetraphylla (Aubl.). How-
ever, this species showed no antibiofilm activity [26].
In order to have cell adhesion onto the surface, the
bacteria synthesize and release exopolysaccharides, which
are considered key components in determining the struc-
ture and functional integrity of biofilm, besides acting as
adhesives and defensive barrier, protecting the cells from
being detached by the flow of substances. Studies report
that adherence of Staphylococcus sp. to polypropylene
films probably occurs through hydrophobic bonds such asct (EtE) and fractions (AqF, HaF and WSF) of T. fagifolia against
Figure 3 Percent inhibition of biofilm formation exhibited by ethanol extract (EtE) and fractions (AqF, HaF and WSF) of T. fagifolia against
S. aureus ATCC 29213 biofilm.
Figure 2 Percent inhibition of biofilm formation exhibited by ethanol extract (EtE) and fractions (AqF, HaF and WSF) of T. fagifolia against
S. epidermidis H111 biofilm.
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Figure 5 Percent inhibition of biofilm formation exhibited by ethanol extract (EtE) and fractions (AqF, HaF and WSF) of T. fagifolia against
S. aureus WB69 biofilm.
Figure 4 Percent inhibition of biofilm formation exhibited by ethanol extract (EtE) and fractions (AqF, HaF and WSF) of T. fagifolia against
S. aureus COL biofilm.
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Figure 6 Effect of ethanol Extract (EtE) and fractions (AqF, HaF and WSF) of T. fagifolia on cell viability of cells of breast cancer - MCF7 within
24 hours.
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electrical charge and surface hydrophobicity of materials
and organisms [27,28].
Thus unknown metabolic changes may be involved in
the inhibition of biofilm formation promoted by EtE and
the fractions AqF, HaF and WSF. Among the possible
changes one can cite a probable decrease in the produc-
tion and release of exopolysaccharides, and a change in
electrical charge and/or hydrophobicity of the bacterial
membrane. To confirm the mechanism by which EtE
and fractions act, more specific protocols need to be
performed.
To verify the cytotoxic effect of ethanol extract and
fractions, we sought to evaluate its effect on cell viability
of tumor cells MCF-7 and non- tumorigenic NIH-3T3.
The cytotoxicity of T. fagifolia ethanol extract and frac-
tions demonstrated marked cytotoxicity to tumor cells,
100% of decreasing cell viability at concentrations ≥
100 μg/mL, as well as a reduction in cell viability ofFigure 7 Effect of ethanol extract (EtE) and fractions (AqF, HaF and WSF) o
24 hours.non-tumorigenic cells NIH-3T3, mainly starting at the
concentration of 50 μg/mL, as shown respectively in
Figures 6 and 7.
Derivatives of plants of the Terminalia genus showed
cytotoxic activity in cancer cell lines by inducing apop-
tosis and against strains of mouse fibroblast NIH-3T3
with reduction in cell viability, such as the results found
in this research [29-31]. However in another study the
acute oral toxicity of EtE and fractions was evaluated in
mice and the authors established an limit oral dose of
2000 mg/kg in male and female mice. Therefore this ex-
tract and fractions could be classified as of low acute
toxicity hazard category 5 according to the United Na-
tions Globally Harmonized System of Classification and
Labeling of Chemicals [17].
The morphological effect of AqF of the ethanol extract
of T. fagifolia on S. aureus ATCC 29213 cells is shown
in Figure 8, we performed atomic force microscopy on
only this selected sample, since it was shown (see above)f T. fagifolia on cell viability of NIH/3T3 murine fibroblasts within
Figure 8 AFM height images showing S.aureus ATCC 29213 before (A and B) and after (C and D) of exposure to the aqueous fraction (AqF) of
the ethanol extract of T. fagifolia.
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and B show the morphology of non-treated bacteria,
while Figure 8C and D show changes in the appearance
in the cell envelope of treated bacteria. It was found that
the treated bacteria had increased roughness on the cell
surface compared to the smooth surfaces of the non-
treated bacteria, and furthermore we see a significant in-
crease in the size of bacteria treated, observe the Z
scales of Figure 8 panels A and B, compared with the
panels C and D. This effect was observed in all the cells
imaged by AFM, and the overall average of all cell
heights are plotted in Figure 9. These increase of the sizeFigure 9 Mean size of treated and untreated (control group)
S. aureus ATCC 29213 obtained by AFM.observed in the Figure 9 may be due to alterations in
membrane integrity caused by AqF, which may lead to
changes in cell osmolarity without the occurrence of
lysis in the observed images. The fact that we can ob-
served cell wall changes, and even cellular size alteration
without gross shape alteration or cell collapse could be
attributed to the fact that the Gram positive cell wall is
mechanically rather strong compared to Gram-negative
organisms.Conclusions
The ethanol extract and fractions showed great antibac-
terial activity against all tested strains, and in many
cases, we also observed antibiofilm activity, with biofilm
formation inhibition over 80% for some strains. As the
extracts showed moderate cytotoxicity for the NIH/3T3
cell lines and potential antitumoral activity, confirming
pharmacological potential of extracts from the T. fagifo-
lia species, which is a common plant in the Brazilian
Cerrado biome and widely used in folk medicine. The
AFM images obtained revealed morphological changes
to the S. aureus ATCC 29213 cell surface caused by AqF,
as well as significant size alterations.Abbreviations
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